Figure 5 | Scientific Reports

Figure 5

From: Potential therapeutic targets for COVID-19 complicated with pulmonary hypertension: a bioinformatics and early validation study

Figure 5The alternative text for this image may have been generated using AI.

Nomogram construction and diagnostic performance validation. (A) SELE, CCL20 were validated in GSE53408.*P < 0.05. (B) SELE, CCL20 were validated in GSE196822.*P < 0.05. (C).The nomogram was established based on the 2 selected candidate biomarkers. Each DEG corresponds to a score. (D) The ROC curve of the nomogram. (E) PR analysis curve (F) decision curve analysis (DCA) curve.

Back to article page